methotrexate has been researched along with Basal Cell Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amici, A; Andreani, C; Bartolacci, C; Belletti, B; Gambini, V; Garulli, C; Giangrossi, M; Iezzi, M; Kalogris, C; Lucci, C; Marchini, C; Pietrella, L; Pucciarelli, S; Tilio, M; Zabaleta, ME | 1 |
1 other study(ies) available for methotrexate and Basal Cell Cancer
Article | Year |
---|---|
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzophenanthridines; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Resistance, Neoplasm; Female; Folic Acid Antagonists; Humans; Isoquinolines; Methotrexate; Mice; Mice, Inbred Strains; Necrosis; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Basal Cell; Random Allocation; Tetrahydrofolate Dehydrogenase; Tumor Burden | 2014 |